- Home
- GPCR vs ATEN Comparison
GPCR vs ATEN Comparison
Compare GPCR & ATEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GPCR
- ATEN
- Stock Information
- Founded
- GPCR 2016
- ATEN 2004
- Country
- GPCR United States
- ATEN United States
- Employees
- GPCR N/A
- ATEN N/A
- Industry
- GPCR
- ATEN EDP Services
- Sector
- GPCR
- ATEN Technology
- Exchange
- GPCR Nasdaq
- ATEN Nasdaq
- Market Cap
- GPCR 1.1B
- ATEN 1.2B
- IPO Year
- GPCR 2023
- ATEN 2014
- Fundamental
- Price
- GPCR $20.91
- ATEN $17.44
- Analyst Decision
- GPCR Strong Buy
- ATEN Strong Buy
- Analyst Count
- GPCR 9
- ATEN 4
- Target Price
- GPCR $75.63
- ATEN $21.50
- AVG Volume (30 Days)
- GPCR 1.1M
- ATEN 621.5K
- Earning Date
- GPCR 11-12-2025
- ATEN 11-06-2025
- Dividend Yield
- GPCR N/A
- ATEN 1.38%
- EPS Growth
- GPCR N/A
- ATEN 21.29
- EPS
- GPCR N/A
- ATEN 0.69
- Revenue
- GPCR N/A
- ATEN $276,445,000.00
- Revenue This Year
- GPCR N/A
- ATEN $10.47
- Revenue Next Year
- GPCR N/A
- ATEN $7.38
- P/E Ratio
- GPCR N/A
- ATEN $25.24
- Revenue Growth
- GPCR N/A
- ATEN 11.04
- 52 Week Low
- GPCR $13.22
- ATEN $13.03
- 52 Week High
- GPCR $45.37
- ATEN $21.90
- Technical
- Relative Strength Index (RSI)
- GPCR 58.61
- ATEN 47.10
- Support Level
- GPCR $18.49
- ATEN $17.29
- Resistance Level
- GPCR $22.25
- ATEN $17.95
- Average True Range (ATR)
- GPCR 1.16
- ATEN 0.38
- MACD
- GPCR 0.15
- ATEN 0.05
- Stochastic Oscillator
- GPCR 66.38
- ATEN 35.11
About GPCR Structure Therapeutics Inc.
Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.
About ATEN A10 Networks Inc.
A10 Networks Inc is a provider of security and infrastructure solutions for on-premises, hybrid cloud, and edge-cloud environments of its multinational enterprise, communication, cloud and web service provider customers who strive to provide business-critical applications and networks that are secure, available, and efficient. As cyber-attacks increase in volume and complexity, the company integrates security and artificial intelligence (AI) enabled capabilities in its solutions that enable its customers to continue to adapt to market trends in hybrid cloud, AI-ready data centers and the ever-increasing need for high-performance, high availability and low latency. The company generates the maximum of its revenue from Americas.